Highly active antiretroviral therapy (HAART) as risk factor for body fat distribution changes in HIV patients.

被引：0
|
作者：
Madeddu, G. [1 ,2 ]
Spanu, A. [2 ]
Chessa, F. [2 ]
Calia, G. M. [1 ]
Lovigu, C. [1 ]
Falchi, A.
Mannazzu, M. [1 ]
Solinas, P. [2 ]
Mura, M. S. [1 ]
Madeddu, G. [1 ,2 ]
机构：
[1] Univ Sassari, Dept Infect Dis, I-07100 Sassari, Italy
[2] Univ Sassari, Dept Nucl Med, I-07100 Sassari, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [31] Effect of highly active antiretroviral therapy (HAART) on HIV associated hypergammaglobulinemia (HgG)
    Younus, F
    Morrison, SA
    Steigbigel, RT
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 272 - 272
  • [32] Arresting HIV-1 evolution with highly active antiretroviral therapy (HAART)
    Persaud, D
    Hermankova, M
    Ruff, C
    Ray, SC
    Siliciano, RF
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1221 - 1221
  • [33] Outcome of HIV associated tuberculosis in the era of highly active antiretroviral therapy (HAART)
    Dheda, K
    Lampe, F
    Lipman, M
    Johnson, M
    THORAX, 2002, 57
  • [34] Pregnancy and HIV disease progression in the era of highly active antiretroviral therapy (HAART)
    Udoji, M
    Barkanic, G
    Rebeiro, P
    Raffanti, S
    Graves, C
    Byrum, B
    Bennett, K
    Kheshti, A
    Sterling, T
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S84 - S84
  • [35] A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naive Patients at the Limbe Regional Hospital, Cameroon
    Dimala, Christian Akem
    Atashili, Julius
    Mbuagbaw, Josephine C.
    Wilfred, Akam
    Monekosso, Gottlieb L.
    PLOS ONE, 2016, 11 (05):
  • [36] Combination therapy for HCV affects the HIV viral load in patients receiving highly active antiretroviral therapy (HAART).
    Kertznus, J
    Molina, EG
    Regev, A
    Schiff, ER
    HEPATOLOGY, 2003, 38 (04) : 746A - 746A
  • [37] Lipodystrophy/lipoatrophy and bone mass loss in HIV patients receiving highly active antiretroviral therapy (HAART)
    Madeddu, G.
    Spanu, A.
    Chessa, F.
    Calia, G. M.
    Lovigu, C.
    Falchi, A.
    Mannazzu, M.
    Solinas, P.
    Mura, M. S.
    Madeddu, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S377 - S378
  • [38] Experience of Polish patients diagnosed with HIV before and after highly active antiretroviral therapy (HAART) availability
    Rogowska-Szadkowska, Dorota
    Chlabicz, Slawomir
    Asiorowski, Jacek G. .
    Zubkiewicz-Zarebska, Anna
    Knysz, Brygida
    HIV & AIDS REVIEW, 2013, 12 (01): : 9 - 13
  • [39] Increasing mortality among HIV/HCV coinfected patients treated with highly active antiretroviral therapy (HAART)
    Macias, J
    Pineda, JA
    Melguizo, I
    Leal, M
    Delgado, J
    Rosa, R
    Sanchez-Quijano, A
    Rivera, JM
    Lissen, E
    JOURNAL OF HEPATOLOGY, 2001, 34 : 150 - 150
  • [40] Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil
    Lima da Silva, Carlos Alberto
    Dourado, Ines
    Dahia, Samir Resack
    Harzheim, Erno
    Rutherford, George Williams
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2008, 68 (03) : 178 - 181
12345